These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25381307)

  • 1. Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.
    Nishijima Y; Kobori H; Kaifu K; Mizushige T; Hara T; Nishiyama A; Kohno M
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):505-8. PubMed ID: 25381307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.
    Isobe S; Ohashi N; Fujikura T; Tsuji T; Sakao Y; Yasuda H; Kato A; Miyajima H; Fujigaki Y
    Clin Exp Nephrol; 2015 Apr; 19(2):231-9. PubMed ID: 24728489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
    Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
    Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z; Xu B; Xu C
    Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
    Jang HR; Jeon J; Park JH; Lee JE; Huh W; Oh HY; Kim YG
    Transl Res; 2014 Nov; 164(5):400-10. PubMed ID: 24929205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
    Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
    Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study.
    Jeon J; Kim DH; Jang HR; Lee JE; Huh W; Kim HY; Kim DJ; Kim YG
    BMC Nephrol; 2020 May; 21(1):180. PubMed ID: 32410703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of urinary angiotensinogen in predicting antiproteinuric effects of angiotensin receptor blocker in non-diabetic chronic kidney disease patients: a preliminary report.
    Jang HR; Lee YJ; Kim SR; Kim SG; Jang EH; Lee JE; Huh W; Kim YG
    Postgrad Med J; 2012 Apr; 88(1038):210-6. PubMed ID: 22357774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary angiotensinogen level is correlated with proteinuria in renal transplant recipients.
    Erdogmus S; Sengul S; Kocak S; Kurultak I; Celebi ZK; Kutlay S; Keven K; Erbay B; Erturk S
    Transplant Proc; 2013 Apr; 45(3):935-9. PubMed ID: 23622592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
    Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
    Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.
    Ishigaki S; Ohashi N; Isobe S; Tsuji N; Iwakura T; Ono M; Sakao Y; Tsuji T; Kato A; Miyajima H; Yasuda H
    Clin Exp Nephrol; 2016 Dec; 20(6):878-884. PubMed ID: 26743744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary renin-angiotensin markers in polycystic kidney disease.
    Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Angiotensinogen and Renin Excretion are Associated with Chronic Kidney Disease.
    Juretzko A; Steinbach A; Hannemann A; Endlich K; Endlich N; Friedrich N; Lendeckel U; Stracke S; Rettig R
    Kidney Blood Press Res; 2017; 42(1):145-155. PubMed ID: 28395289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease.
    Yamamoto T; Nakagawa T; Suzuki H; Ohashi N; Fukasawa H; Fujigaki Y; Kato A; Nakamura Y; Suzuki F; Hishida A
    J Am Soc Nephrol; 2007 May; 18(5):1558-65. PubMed ID: 17409316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.